Monday, May 28, 2012
Advertisement

News: May 28, 2012

Newer Drugs Beat Gleevec in Head-to-Head Trials
SATURDAY, June 5 (HealthDay News) -- Two new drugs, dasatinib (Sprycel) and nilotinib (Tasigna), appear better than imatinib (Gleevec) in treating patients with newly diagnosed chronic myeloid leukemia and should be considered as first-line treatm...
Scientists Gain Insight Into Blood Cancer's Progression
FRIDAY, Feb. 20 (HealthDay News) -- U.S. researchers say they've spotted a mechanism by which chronic myeloid leukemia (CML) progresses into a deadlier stage. The finding may improve patient outcomes, they said.
Healthline Tools
3D Body Maps
Advertisement
Healthline : Connect to Better Health

Follow on Twitter Follow on Facebook
More:
Site Map
MyHealthline
Health Directories:
Health and Wellness A to Z
Health Blogs A to Z
Diseases A to Z
Learning Centers A to Z
Drugs A to Z
Drugs by Disease
Supplements A to Z
Supplements by Disease
Symptoms A to Z
Symptoms by Disease
Slideshows A to Z
Videos A to Z
Videos by Disease
Company Info:
About Healthline.com
Editorial Staff
Terms of Use
Privacy Policy
Advertising & Sponsorship Policy
Advertise With Us
About Healthline Networks
Careers
Copyright © 2005 - 2012 Healthline Networks, Inc. All rights reserved.
Healthline is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations. more details